Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05065294
PHASE2

Psilocybin Therapy for Depression in Bipolar II Disorder

Sponsor: University of California, San Francisco

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.

Official title: An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

14

Start Date

2022-01-28

Completion Date

2025-07

Last Updated

2024-09-25

Healthy Volunteers

No

Interventions

DRUG

Psilocybin therapy

\- Psilocybin administration session 10mg-25mg delivered orally with psychological support and monitoring

Locations (1)

University of California, San Francisco

San Francisco, California, United States